![Marie-Claude Fournié-Zaluski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marie-Claude Fournié-Zaluski
Plus aucun poste en cours
Profil
Marie-Claude Fournié-Zaluski is the founder of Pharmaleads SA, a company founded in 2000.
She also worked as a Professor at Université Pierre et Marie Curie.
Dr. Fournié-Zaluski holds a doctorate degree from Université Pierre et Marie Curie.
Anciens postes connus de Marie-Claude Fournié-Zaluski
Sociétés | Poste | Fin |
---|---|---|
Université Pierre et Marie Curie | Corporate Officer/Principal | - |
Pharmaleads SA
![]() Pharmaleads SA Pharmaceuticals: MajorHealth Technology Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France. | Fondateur | - |
Formation de Marie-Claude Fournié-Zaluski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Pharmaleads SA
![]() Pharmaleads SA Pharmaceuticals: MajorHealth Technology Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France. | Health Technology |
Université Pierre et Marie Curie | Consumer Services |